Variant report
Variant | esv3692787 |
---|---|
Chromosome Location | chr3:68897115-68925972 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:67022337..67023183-chr3:68925421..68925921,2 | K562 | blood: | |
2 | chr3:67159823..67160870-chr3:68924556..68925868,3 | MCF-7 | breast: | |
3 | chr3:66988494..66989399-chr3:68925421..68925952,2 | K562 | blood: | |
4 | chr3:67952201..67952773-chr3:68925063..68925992,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563152177 | chr3:68904669-68904670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529008475 | chr3:68904675-68904676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147925182 | chr3:68904678-68904679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573799639 | chr3:68904683-68904684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548299370 | chr3:68904698-68904699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542670157 | chr3:68904722-68904723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3943100 | chr3:68904737-68904738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs527771652 | chr3:68904762-68904763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6797048 | chr3:68904763-68904764 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs570824443 | chr3:68904765-68904766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78281648 | chr3:68904779-68904780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556852940 | chr3:68904794-68904795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545051271 | chr3:68904825-68904826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550903723 | chr3:68904827-68904828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189624756 | chr3:68904843-68904844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148835442 | chr3:68904912-68904913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555453055 | chr3:68904921-68904922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143452020 | chr3:68904999-68905000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565604178 | chr3:68905004-68905005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541098658 | chr3:68905047-68905048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569406164 | chr3:68905057-68905058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181951944 | chr3:68905065-68905066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543315834 | chr3:68905072-68905073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563214802 | chr3:68905077-68905078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2171871 | chr3:68905094-68905095 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs185908781 | chr3:68905142-68905143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559479609 | chr3:68905148-68905149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2171870 | chr3:68905151-68905152 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs368645713 | chr3:68905152-68905153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561281653 | chr3:68905185-68905186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367637060 | chr3:68905191-68905192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs150919824 | chr3:68905212-68905213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13078150 | chr3:68905216-68905217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142286652 | chr3:68905228-68905229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77310400 | chr3:68905274-68905275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116033162 | chr3:68905287-68905288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562943503 | chr3:68905302-68905303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576459126 | chr3:68905310-68905311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549339047 | chr3:68905316-68905317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9822138 | chr3:68905340-68905341 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs146116588 | chr3:68905368-68905369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557788411 | chr3:68905373-68905374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190728653 | chr3:68905378-68905379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536617745 | chr3:68905387-68905388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111697586 | chr3:68905396-68905397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183612384 | chr3:68910236-68910237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548621500 | chr3:68910254-68910255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561939347 | chr3:68910260-68910261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527655086 | chr3:68910269-68910270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548123165 | chr3:68910305-68910306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68904600-68905400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr3:68904600-68905400 | Enhancers | HMEC | breast |
3 | chr3:68904800-68905200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr3:68910200-68912000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr3:68910800-68911200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr3:68924000-68924200 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
7 | chr3:68925200-68925400 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr3:68925200-68925400 | Enhancers | Fetal Kidney | kidney |
9 | chr3:68925400-68933600 | Weak transcription | Colon Smooth Muscle | Colon |